Binder's disposition followed vesting of performance-based awards tied to the company's total shareholder return relative to ...

By Milliam MurigiKenya’s animal feed manufacturers are urging the government to allow access to genetically modified (GM) ...

As digital technologies continue to reshape industries and redefine the global economy, governments are increasingly competing not only for capital but also for innovation.

When Chinese drug developers need to see exactly how an experimental medicine binds to its target protein, or materials ...

In the latest close session, Recursion Pharmaceuticals (RXRX) was down 1.87% at $2.89. This change lagged the S&P 500's daily loss of 0.19%. At the same time, the Dow lost 0.59%, and the tech-heavy ...

Researchers developed a 220-sample pan-cancer patient-derived organoid platform that faithfully mirrors tumors and may ...

Biogen has found a successor to longtime legal chief Susan Alexander, tapping former Vertex Pharmaceuticals executive and ...

Cathie Wood of Ark Invest first bought shares of Beam Therapeutics (BEAM 4.14%), a biotech focused on precision genetic ...

The Charlottesville, Va. facility is designed to provide the state's ever-evolving biotechnology industry space to ...

A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech ...

Revvity, Inc. announced that its Revvity Signals Software business is launching Signals for Startups, a new program designed to help emerging biotechnology companies adopt scalable informatics ...

Pain drug developer Latigo Biotherapeutics has joined a queue of more than half a dozen other biotechnology startups that announced this month plans to go public. Founded in 2018 by the venture ...